ArticleCureus2025
A Rare Case of Postpartum Portal Vein Thrombosis in a Young Patient With Heterozygous Prothrombin G20210A Mutation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Portal vein thrombosis (PVT) is most commonly associated with cirrhosis due to the reduced blood flow through the liver. However, its occurrence in non-cirrhotic individuals is rare and typically linked to hypercoagulable states. The postpartum period is a recognized hypercoagulable state, yet PVT in this context remains uncommon. We report a rare case of PVT in a 25-year-old female patient diagnosed with a heterozygous prothrombin G20210A mutation, presenting six weeks after a cesarean section with recurrent epigastric pain, fever, and elevated cholestatic liver enzymes. Multifactorial etiologies, including the hypercoagulable postpartum period, prolonged bed rest, and the presence of the prothrombin G20210A mutation, contributed to the development of venous thrombosis. This case underscores the synergistic effect of genetic predisposition and pregnancy-related changes on thrombotic risk. It also highlights the importance of maintaining a high index of suspicion for PVT in postpartum females presenting with epigastric pain and fever. Our patient was successfully managed with anticoagulation therapy, which resolved her symptoms and normalized her liver function tests. This case raises critical questions about the long-term management of thrombotic risk in similar patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.